Thermo Fisher Scientific Inc to buy Patheon NV for $7.2bn
Thermo Fisher Scientific Inc has announced its intention to buy Patheon NV in a deal agreed by both firms’ boards.
Archives for May 14, 2017
AB Science suspends French masitinib trials after ANSM finds deviations
AB Science SA has halted French trials of its Ph III drug candidate masitinib after regulators uncovered good clinical practice (GCP) and pharmacovigilance deviations in an earlier study.
Connecticut ‘injects’ in SCA Pharma
Injectable pharmaceuticals manufacturer, SCA Pharmaceuticals, is building a 90,000 square-foot manufacturing facility in Windsor, Connecticut, US.
Sanofi’s €250m AI-driven R&D collaboration for metabolic disease
Sanofi and Artificial Intelligence (AI)-driven Exscientia have announced a €250m ($271.9m) drug target research collaboration and licence option agreement.
MedAvante, ProPhase acquisition to transform CNS market, says WCG CEO
WIRB-Copernicus Group (WCG) has acquired MedAvante and ProPhase, bolstering the company’s presence in the central nervous system (CNS) and behavioral health assessment markets.
AG Mednet launches Judi to help sponsors, CROs manage clinical events
AG Mednet's SaaS solution, Judi, helps sponsors and contract research organizations (CROs) manage clinical events from trigger to final adjudication.
RBM provider expands in US Northeast to support CRO, sponsor demand
CluePoints is expanding its US-based operations with a new office in Wayne, PA to better serve its customers in the US Northeast/Mid-Atlantic regions.
How Thermo Fisher buying Patheon could simplify pharma supply chains
Thermo Fisher Scientific is set to buy contract manufacturer Patheon, but what would this mean for the life science tech firm?
Extractables and leachables analysis of pharmaceutical products
Paid for and content provided by RSSL
A crucial undertaking when releasing pharmaceutical products for the market, is to determine the purity of the final product, necessitating the need to determine its impurity profile. Traditionally, this was concerned only with those impurities arising...